ZBH - Zimmer Biomet Holdings Inc Stock Price, Fair Value and News

$109.26-1.69 (-1.52%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ZBH Price Action

Last 7 days

-0.6%

Last 30 days

3.9%

Last 90 days

-3.7%

Trailing 12 Months

-3.2%

ZBH RSI Chart

ZBH Valuation

Market Cap

21.8B

Price/Earnings (Trailing)

20.07

Price/Sales (Trailing)

2.86

EV/EBITDA

14.4

Price/Free Cashflow

15.92

ZBH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ZBH Fundamentals

ZBH Revenue

Revenue (TTM)

7.6B

Rev. Growth (Yr)

4.03%

Rev. Growth (Qtr)

-6.07%

ZBH Earnings

Earnings (TTM)

1.1B

Earnings Growth (Yr)

53.1%

Earnings Growth (Qtr)

2.59%

ZBH Profitability

EBT Margin

13.59%

Return on Equity

8.76%

Return on Assets

4.99%

Free Cashflow Yield

6.28%

ZBH Investor Care

Dividend Yield

0.88%

Dividend/Share (TTM)

0.96

Buy Backs (1Y)

4.74%

Diluted EPS (TTM)

5.25

ZBH Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	7.5B	7.5B	7.6B	0
2023	7.1B	7.2B	7.3B	7.4B
2022	6.9B	6.9B	6.9B	6.9B
2021	6.8B	7.4B	7.1B	6.8B
2020	7.8B	7.0B	7.1B	7.0B
2019	7.9B	7.9B	7.9B	8.0B
2018	7.8B	7.9B	7.9B	7.9B
2017	7.8B	7.8B	7.7B	7.8B
2016	6.8B	7.5B	7.6B	7.7B
2015	4.6B	4.6B	5.3B	6.0B
2014	4.6B	4.7B	4.7B	4.7B
2013	4.5B	4.5B	4.6B	4.6B
2012	4.5B	4.5B	4.5B	4.5B
2011	4.3B	4.4B	4.4B	4.5B
2010	4.2B	4.2B	4.2B	4.2B
2009	0	0	0	4.1B

Get all data in R, Python etc through our Historical Stock Data APIs

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

CEO	Mr. Ivan Tornos
WEBSITE	zimmerbiomet.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	18000

Zimmer Biomet Holdings Inc Frequently Asked Questions

What is the ticker symbol for Zimmer Biomet Holdings Inc? What does ZBH stand for in stocks?

ZBH is the stock ticker symbol of Zimmer Biomet Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zimmer Biomet Holdings Inc (ZBH)?

As of Wed Nov 20 2024, market cap of Zimmer Biomet Holdings Inc is 21.75 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZBH stock?

You can check ZBH's fair value in chart for subscribers.

Is Zimmer Biomet Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether ZBH is over valued or under valued. Whether Zimmer Biomet Holdings Inc is cheap or expensive depends on the assumptions which impact Zimmer Biomet Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZBH.

What is Zimmer Biomet Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, ZBH's PE ratio (Price to Earnings) is 20.07 and Price to Sales (PS) ratio is 2.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZBH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zimmer Biomet Holdings Inc's stock?

In the past 10 years, Zimmer Biomet Holdings Inc has provided 0.002 (multiply by 100 for percentage) rate of return.